Byfavo Injection, Powder, Lyophilized, For Solution
Product Images NDC 71390-011

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Byfavo (NDC 71390-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Acacia Pharma, Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Byfavo 01)

Chemical structure diagram depicting the molecular structure of remimazolam besylate, showing multiple ring systems and functional groups characteristic of the compound.*

FDA Label Image

Principal Display Panel (10 Vial Carton)

Label for BYFAVO (remimazolam) injection for intravenous use, lyophilized powder for solution. Each vial contains 20 mg remimazolam besylate equivalent to 2.72 mg remimazolam per mL. The package includes 10 vials of 20 mg each. Labeler is Acacia Pharma, Ltd., manufactured in Italy. Storage instructions and formulation details including sodium chloride, Dextrose, and pH adjustment agents are provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.